Charles River Labs (NYSE:CRL) is pursuing a sale of the company that could fetch as much as $40/share, and it's "just a matter of time" before a deal is completed, the Deal Reporter says. R.W. Baird expects shares to trade higher on the speculation unless management denies the story. CRL +2.1% premarket.
Charles River Labs (NYSE:CRL) is pursuing a sale of the company that could fetch as much as...
Recommended For You
More Trending News
About CRL Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CRL | - | - |
Charles River Laboratories International, Inc. |